Dr. Allison, Ph.D., is Chairman, Immunology Program, David H. Koch Chair in Immunologic Studies, Attending Immunologist, Department of Medicine, Investigator, Howard Hughes Medical Institute, Memorial Sloan-Kettering Cancer Center.

“Dr. Allison has long had a particular interest in the field of immunology and its potential clinical applications, an interest dating back to a grad school project that involved the discovery of an enzyme which could cure leukemia in mice. After receiving his doctoral degree from University of Texas, Austin, TX, and finishing a postdoctoral fellowship in the Department of Molecular Immunology at Scripps Clinic and Research Foundation, he accepted a faculty position at the University of Texas System Cancer Center. This was followed by a year as a visiting scholar at Stanford University School of Medicine, then a 20-year stint at the University of California, Berkeley, where he was a professor in the Division of Immunology and Director of the Cancer Research Laboratory. Dr. Allison's research has focused on the mechanisms that regulate the immunological responses of T lymphocytes, also known as T cells, with an emphasis on the development of strategies to manipulate those responses to develop novel tumor immunotherapy approaches. (Cited from http://www.mskcc.org/mskcc/html/52102.cfm)”